Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Opportunities for future biological therapy in SLE

D Wofsy1, D I Daikh

  • 1Department of Medicine, Department of Veterans Affairs Medical Center, San Francisco, CA 94121, USA.

Bailliere'S Clinical Rheumatology
|January 16, 1999
PubMed
Summary

New therapies targeting immune responses show promise for autoimmune diseases. Advances in antibody and DNA technology enable selective inhibition of immune cells and molecules, offering hope for conditions like lupus.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Hormones, handedness, and autoimmunity.

Immunology today·2014
Same author

[Not Available].

Immunology today·2014
Same author

Treatment of autoimmune diseases by inhibition of T-cell costimulation.

Modern rheumatology·2014
Same author

Mycophenolate mofetil as induction and maintenance therapy for lupus nephritis: rationale and protocol for the randomized, controlled Aspreva Lupus Management Study (ALMS).

Lupus·2007
Same author

Block and tackle: CTLA4Ig takes on lupus.

Lupus·2005
Same author

The immune tolerance network and rheumatic disease: immune tolerance comes to the clinic.

Arthritis and rheumatism·2001

Area of Science:

  • Immunology
  • Molecular Biology
  • Autoimmune Disease Research

Background:

  • Monoclonal antibodies and recombinant DNA technology allow precise targeting of immune components.
  • Understanding immune mechanisms is crucial for developing treatments for autoimmune conditions.

Purpose of the Study:

  • To explore rational therapeutic strategies for autoimmune diseases.
  • To investigate methods for modulating T cell activation and cytokine activity in autoimmunity.

Main Methods:

  • Utilizing advancements in antibody and DNA technologies for selective inhibition.
  • Developing strategies to influence T cell-surface interactions.
  • Modulating specific cytokines involved in autoimmune processes.

Main Results:

Related Experiment Videos

  • Identified distinct cell subsets, surface molecules, and secreted products involved in immune responses.
  • Clarified mechanisms underlying autoimmune disease development.
  • Demonstrated promise of targeted strategies in animal models for systemic lupus erythematosus.

Conclusions:

  • Targeted immunotherapies offer a promising avenue for treating autoimmune diseases.
  • These strategies may soon translate into effective human therapies.
  • Further research into immune modulation holds potential for new autoimmune treatments.